Sofosbuvir + simeprevir +/-ribavirin treatment is efficient in genotype 4 chronic hepatitis C patients: results of a large international cohort.

Moreno, C; Derbala, M; Nguyen-Khac, E; Babatin, M; Rosa, I; Alzaabi, M; Hanslik, B; Mangia, A; Asselah, T; Buggisch, P; Mauss, S; Sersté, T; DELWAIDE, Jean; Alkaabi, S; Pariente, A; Remy, A; Alghamdi, A; Cadranel, JF; Mohiuddin, S; Degré, D

Paper published in a journal (Scientific congresses and symposiums)

Moreno, C; Derbala, M; Nguyen-Khac, E et al.

2016 • In Hepatology, 64 (1), p. 1990

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/203484

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

AASLD 2016 gen 4 001.jpg

Publisher postprint (726.61 kB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

Gastroenterology & hepatology

Author, co-author :

Moreno, C

Derbala, M

Nguyen-Khac, E

Babatin, M

Rosa, I

Alzaabi, M

Hanslik, B

Mangia, A

Asselah, T

Buggisch, P

More authors (10 more)

Language :

English

Title :

Sofosbuvir + simeprevir +/-ribavirin treatment is efficient in genotype 4 chronic hepatitis C patients: results of a large international cohort.

Publication date :

2016

Event name :

The Liver Meeting AASLD

Event place :

Boston, United States

Event date :

11-15 Novembre 2016

Audience :

International

Journal title :

Hepatology

ISSN :

0270-9139

eISSN :

1527-3350

Publisher :

Wiley, Hoboken, United States - New Jersey

Volume :

Issue :

Pages :

A1990

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 17 November 2016

Statistics

Number of views

59 (3 by ULiège)

Number of downloads

14 (0 by ULiège)

More statistics